Lilly Wins Order Banning Generic Cymbalta Sales

Law360, New York (April 27, 2011, 10:28 PM EDT) -- A federal judge in Indiana on Wednesday barred a group of pharmaceutical companies, including Impax Laboratories Inc. and Cobalt Laboratories Inc., from peddling generic versions of Eli Lilly & Co.'s antidepressant Cymbalta.

U.S. District Court Judge Tanya Walton Pratt entered final judgment against the group, prohibiting the sale of a Cymbalta generic and requiring that the U.S. Food and Drug Administration be notified that the defendants were no longer seeking approval for an abbreviated new drug application.

Lilly argued that the group were bound by Judge...
To view the full article, register now.